Breaking News Instant updates and real-time market news.

RTRX

Retrophin

$13.55

-3.84 (-22.08%)

07:29
08/23/19
08/23
07:29
08/23/19
07:29

Retrophin price target lowered to $20 from $36 at Barclays

Barclays analyst Gena Wang said the topline miss in the FORT Phase 3 trial was "an obvious disappointment," but also "not totally unexpected." Given no signs of clinical benefit, the Fosmet program is expected to be discontinued, said Wang, who is now looking toward the sparsentan data in focal segmental glomerulosclerosis in the first half of 2021. Following the Fosmet news, Wang lowered her price target on Retrophin shares to $20 from $36 and keeps an Overweight rating on the stock.

RTRX Retrophin
$13.55

-3.84 (-22.08%)

04/22/19
LEHM
04/22/19
INITIATION
Target $36
LEHM
Overweight
Retrophin initiated with an Overweight at Barclays
Barclays analyst Geoff Meacham started Retrophin with an Overweight rating and $36 price target.
07/01/19
ADAM
07/01/19
NO CHANGE
Target $41
ADAM
Buy
Retrophin price target raised to $41 from $37 at Canaccord
Canaccord analyst Michelle Gilson raised her price target on Retrophin to $41 from $37 following the FDA approval of its new Thiola formulation for the treatment of cystinuria. The new formulation frees patients from planning doses around meals and its revenue stream will support earnings through 2022. Gilson reiterated her Buy rating on Retrophin shares.
08/22/19
LEER
08/22/19
NO CHANGE
Target $35
LEER
Outperform
Retrophin price target lowered to $35 from $40 at SVB Leerink
08/22/19
JMPS
08/22/19
NO CHANGE
JMPS
Retrophin price target lowered to $26 from $32 at JMP Securities
JMP Securities analyst Liisa Bayko reiterated an Outperform rating on Retrophin, but is lowering her price target on shares to $26 from $32 after Fosmetpantotenate missed both primary and secondary endpoints in the Phase 3 FORT study for PKAN, formerly called Hallervorden-Spatz syndrome. The drug did not "demonstrate a difference between placebo on the primary endpoint" although it was generally safe and well tolerated. Bayko had viewed the trial as a long shot, and called the results "disappointing but not unexpected." The analyst noted that Retrophin management decided to discontinue investment in the drug following the trial.

TODAY'S FREE FLY STORIES

WTR

Aqua America

$43.88

0.51 (1.18%)

16:56
09/17/19
09/17
16:56
09/17/19
16:56
Hot Stocks
Aqua America subsidiary to buy municipal wastewater system for $276.5M »

Aqua America announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$28.49

0.31 (1.10%)

16:54
09/17/19
09/17
16:54
09/17/19
16:54
Syndicate
Invitation Homes files to sell 44M shares of common stock for holders »

Morgan Stanley, Citigroup…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MODN

Model N

$28.43

0.275 (0.98%)

, IQV

Iqvia

$152.93

2.14 (1.42%)

16:49
09/17/19
09/17
16:49
09/17/19
16:49
Hot Stocks
Model N names Suresh Kannan as Chief Product Officer »

Model N (MODN) announced…

MODN

Model N

$28.43

0.275 (0.98%)

IQV

Iqvia

$152.93

2.14 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 08

    Oct

  • 12

    Nov

GWW

Grainger

$291.76

-4.29 (-1.45%)

16:49
09/17/19
09/17
16:49
09/17/19
16:49
Conference/Events
Grainger management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 23

    Oct

ACGL

Arch Capital

$40.89

0.33 (0.81%)

16:48
09/17/19
09/17
16:48
09/17/19
16:48
Conference/Events
Arch Capital management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

TOL

Toll Brothers

$40.68

-0.11 (-0.27%)

16:47
09/17/19
09/17
16:47
09/17/19
16:47
Hot Stocks
Toll Brothers president Hartman sells over 40,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$28.56

0.31 (1.10%)

16:45
09/17/19
09/17
16:45
09/17/19
16:45
Hot Stocks
VA Partners reports 8.8% stake in KKR »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

ADBE

Adobe

$284.59

1.54 (0.54%)

16:44
09/17/19
09/17
16:44
09/17/19
16:44
Hot Stocks
Adobe down 3.5% at $274.65/share after reducing Digital Experience bookings view »

Shares of Adobe are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Oct

  • 27

    Oct

16:41
09/17/19
09/17
16:41
09/17/19
16:41
General News
API crude inventories for week of September 13 »

API reports that crude…

CAL

Caleres

$22.08

-0.71 (-3.12%)

16:35
09/17/19
09/17
16:35
09/17/19
16:35
Hot Stocks
Caleres appoints Angela Bass as Chief Human Resources Officer »

Caleres announced Angela…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 02

    Oct

CHSP

Chesapeake Lodging

$27.20

-0.2 (-0.73%)

, PK

Park Hotels & Resorts

$25.80

-0.32 (-1.23%)

16:34
09/17/19
09/17
16:34
09/17/19
16:34
Hot Stocks
Chesapeake Lodging completes sale of two new York hotels for $138M »

Chesapeake Lodging Trust…

CHSP

Chesapeake Lodging

$27.20

-0.2 (-0.73%)

PK

Park Hotels & Resorts

$25.80

-0.32 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAE

CAE

$25.54

0.4 (1.59%)

16:34
09/17/19
09/17
16:34
09/17/19
16:34
Conference/Events
CAE management to meet with CIBC »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 13

    Nov

UNVR

Univar

$22.68

0.29 (1.30%)

16:34
09/17/19
09/17
16:34
09/17/19
16:34
Hot Stocks
Univar selected as distributor for Unovyn's chlorinated paraffins in U.S. »

Univar Solutions has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SGMS

Scientific Games

$23.62

-0.3 (-1.25%)

16:33
09/17/19
09/17
16:33
09/17/19
16:33
Hot Stocks
Scientific Games' Haddrill sells 45,681 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CLPHY

CLP Holdings

$0.00

(0.00%)

16:32
09/17/19
09/17
16:32
09/17/19
16:32
Conference/Events
CLP Holdings management to meet with CIBC »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CBAY

CymaBay

$5.86

-0.02 (-0.34%)

16:31
09/17/19
09/17
16:31
09/17/19
16:31
Hot Stocks
CymaBay announces departure of Chief Medical Officer Pol Boudes »

CymaBay Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

AMR

Alta Mesa Resources

$0.12

0.0062 (5.64%)

16:31
09/17/19
09/17
16:31
09/17/19
16:31
Hot Stocks
Alta Mesa Resources receives Nasdaq notice of delisting »

Alta Mesa Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGA

Magna

$53.89

0.05 (0.09%)

16:30
09/17/19
09/17
16:30
09/17/19
16:30
Conference/Events
Magna management to meet with CIBC »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 19

    Sep

  • 24

    Sep

16:30
09/17/19
09/17
16:30
09/17/19
16:30
Options
Preliminary option volume of 17.2M today »

Preliminary option volume…

16:30
09/17/19
09/17
16:30
09/17/19
16:30
General news
Treasury Market Summary »

Treasury Market Summary:…

FB

Facebook

$188.13

1.89 (1.01%)

16:29
09/17/19
09/17
16:29
09/17/19
16:29
Hot Stocks
Facebook's Zuckerberg says Oversight Board a way to address 'harmful content' »

Mark Zuckerberg, the CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

TTWO

Take-Two

$130.79

2.085 (1.62%)

16:28
09/17/19
09/17
16:28
09/17/19
16:28
Hot Stocks
Take-Two's Rockstar debuts own PC game launcher »

Take-Two's Rockstar,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 13

    Nov

IOTS

Adesto Technologies

$10.63

-0.66 (-5.85%)

16:27
09/17/19
09/17
16:27
09/17/19
16:27
Syndicate
Adesto Technologies files to sell Convertible Senior Notes due 2024 »

The amount was not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$284.59

1.54 (0.54%)

16:25
09/17/19
09/17
16:25
09/17/19
16:25
Earnings
Adobe sees FY19 digital experience bookings growth greater than 20% »

Adobe said in its Q3 call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Oct

  • 27

    Oct

JCAP

Jernigan Capital

$20.00

-0.04 (-0.20%)

, CUBE

CubeSmart

$35.92

0.82 (2.34%)

16:21
09/17/19
09/17
16:21
09/17/19
16:21
Hot Stocks
Jernigan Capital acquires membership interests in six properties »

Jernigan Capital (JCAP)…

JCAP

Jernigan Capital

$20.00

-0.04 (-0.20%)

CUBE

CubeSmart

$35.92

0.82 (2.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.